One new sesquiterpene, (4E)-1-bromo-5-[(1'S*,3'R*)-3'-bromo-2',2'-dimethyl-6'-methylenecyclohexyl]-3-methylpent-4-ene-2,3-diol (1), and fifteen known sesquiterpenes, isopalisol (2), luzonensol (3), palisadin B (4), aplysistatin (5), palisadin A (6), 4-hydroxyl-palisudin C (7), 5-acetoxypalisadin B (8), 10-hydroxyaristolan-9-one (9), aristol-8-en-1-one (10), aristolan-9-en-1-one (11), aristolan-1(10)-en-9-one (12), aristolan-1(10)-en-9-ol (13), aristolan-1(10),8-diene (14), aristolan-1,9-diene (15) and aristofone (16), were isolated from a sample of marine red alga Laurencia similis. Their structures were established by detailed NMR spectroscopic analysis and comparison with literature data. Compounds 2-9, and 16 were isolated for the first time from this species. All these metabolites were submitted for a cytotoxicity assay against the tumor cell line BEL7402 (human liver adenocarcinoma), but all of them were found inactive (IC 50 > 10 μg/mL).
Introduction
Red algae of the genus Laurencia have proved to be a rich source of secondary metabolites, mainly sesquiterpenes, C 15 -acetogenins, and a few di-and triterpenes. More than 300 have been characterized from some 40 species collected in various parts of the world since the 1960s [1] . Many of these OPEN ACCESS metabolites have been reported to possess a variety of biological activities, such as antimicrobial [2] , antifeedant [3] , anthelmintic [4, 5] , and cytotoxic activities [6, 7] . 
OH
Within the context of our program to systematically assess the chemical and biological diversity of marine algae distributed along the Chinese coast, further investigations of the chemical constituents of the red alga L. similis, collected from Sanya Bay, Hainan Province, led to the isolation and identification of one new sesquiterpene, which is described in this paper, together with 15 known sesquiterpenes.
Results and Discussion
The dried and powdered alga L. similis was extracted with 95% EtOH at room temperature. The concentrated extracts were partitioned between H 2 O and EtOAc. The EtOAc-soluble fraction was purified by a combination of silica gel and Sephadex LH-20 column chromatography, as well as preparative TLC procedures, to yield compounds 1-16.
Compound 1 was isolated as colorless oil, and showed IR absorptions for hydroxy functional group (3410 cm -1 (Table  1 ) demonstrated the presence of three methyls, three methylenes, three methines, and two quaternary carbons in addition to the four olefinic carbons. Comparison of the NMR data of 1 with the Compound 2 suggested that it had the same cyclohexane ring portion. This portion could be connected by HMBC data, including from H 3 -8' and H 3 -9' to C-1', C-2' and C-3', from H 2 -7' to C-1' and C-5'. The third spin system was also established by the HMBC data, including between H 3 -6 and C-2, C-3 and C-4, between H-4 and C-3 and C-1'. Furthermore, the connectivity of C-1' and C-5 was also established by the HMBC data from H-1' to C-4, C-5, C-2', C-6', C-7' and C-8'. Thus, the planar structure of 1 was clearly established. 
The relative configurations of 1 at C-1' and C-3' were shown to be the same as those of γ-ionone by analysis of a NOESY experiment and detailed NMR data comparison [8, 9] . In the 2D NOESY spectrum, the observed correlations of H-1' with H-3' and Me-8' indicated the cis-orientation for these protons. The stereochemistry at C-3 and C-4 could not be determined unambiguously. The above spectral evidences established the structure for compound 1:
Compounds 2-16 were identified as: isopalisol (2), luzonensol (3), palisadin B (4), aplysistatin (5), palisadin A (6), 4-hydroxyl-palisudin C (7), 5-acetoxypalisadin B (8), 10-hydroxyaristolan-9-one (9), aristol-8-en-1-one (10), aristolan-9-en-1-one (11), aristolan-1(10)-en-9-one (12), aristolan-1(10)-en-9-ol (13), aristolan-1(10), 8-diene (14) , aristolan-1,9-diene (15), aristofone (16) ,respectively, by spectroscopic analysis ( 1 H-NMR, 13 C-NMR, and MS) and comparisons with literature data [10] [11] [12] [13] [14] [15] [16] [17] . Compounds 2-8 and 16 were isolated from this specimen for the first time.
Compounds 1-16 were evaluated for the cytotoxicity against a human liver adenocarcinoma (BEL7402) cell line. However, all of them were found to be inactive (IC 50 >10 μg/mL). 
Experimental

General
1D and 2D NMR spectra were obtained on a Bruker Avance500 spectrometer at 500 and 125 MHz for 1 H and 13 C, respectively. Mass spectra were collected using a VG Autospec 3000 mass spectrometer. Column chromatography (CC) was performed on silica gel (200-300 mesh, Qingdao Haiyang Chemical Co., Qingdao, China) and Sephadex LH-20 (Sigma). TLC was carried out with precoated silica gel plates (GF-254, Qingdao Haiyang Chemical Co., Qingdao, China).
Alga material
The marine red alga L. similis was collected from Hainan coastlines of People's Republic of China, in 
Extraction and Isolation
The air-dried alga L. similis (1.1 kg) was powdered and extracted with 95% EtOH at room temperature. The resulting extractive solution was filtered and evaporated under reduced pressure (<45 ℃) to yield a dark residue (34.2 g), and then partitioned between H 2 O and EtOAc. The EtOAc phase (28.5 g) was subjected to column chromatography (CC) over silica gel eluting with a gradient of increasing EtOAc in petroleum ether (PE, 0~100%) to give 7 fractions on the basis of TLC analysis. Fraction III (1.9 g) were further chromatographed over Sephadex LH-20 eluting with PE-CHCl 3 -MeOH (5:5:1) to yield compounds 1 (6.8 mg), 2 (5.7 mg), 4 (6.7 mg), 5 (7.3 mg) and 8 (7.3 mg) respectively. Fraction IV (0.6 g) was further chromatographed over Si gel eluting with a gradient of increasing EtOAc (35-100%) in PE to yield 3 (8.3 mg), 6 (7.9 mg), 10 (8.6 mg), 11 (10.0 mg), 14 (5.6 mg) and 16 (5.6 mg). Fraction Ⅴ (3.6 g) was decolored by column chromatography over Sephadex LH-20 eluting with PE-CHCl 3 -MeOH (5:5:1) and preparative TLC (PE/EtOAc 40:3) to afford compound 7 (7.3 mg), 9 (8.3 mg), 12 (11.1 mg), 13 (9.7 mg) and 15 (7.5 mg). Table 1 ); 13 C NMR data (CDCl 3 ) (see Table 1 00(3H, s, H 3 -14), 1.25(3H, s, H 3 -15), 1.37(3H, s, H 3 -13), 1.55(1H, m, H-8α), 1.85(1H, m, H-8β 
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